Hunter, Francis W. http://orcid.org/0000-0002-9970-8679
Barker, Hilary R.
Lipert, Barbara
Rothé, Françoise
Gebhart, Géraldine
Piccart-Gebhart, Martine J.
Sotiriou, Christos
Jamieson, Stephen M. F. http://orcid.org/0000-0002-5485-9211
Article History
Received: 24 June 2019
Revised: 22 October 2019
Accepted: 25 October 2019
First Online: 16 December 2019
Competing interests
: F.W.H. is an employee and shareholder of Johnson & Johnson, Inc., received honoraria from Threshold Pharmaceuticals, Inc., received research funding from Roche and received consulting fees from Merck KGaA. M.J.P.-G. received honoraria and consulted for Genentech/Roche. C.S. is named on patents on gene expression and methylation signatures, participated in advisory boards, and/or spoke at meetings, and/or was a recipient of travel support for participation in medical meetings for/from (in alphabetical order): Amgen, Astellas, AstraZeneca, Bayer, Celgene, Nanostring Technologies, Novartis, Pfizer, Puma Biotechnology, Roche, and Seattle Genetics. Other authors declare no conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.